Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,599 public trials 548 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Active, Not Recruiting

Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)

NCT03915184

Conditions
Blood Protein Disorders, Carcinoma, Cardiovascular Diseases, +14 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UCSF San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Safety, Activity and Cell Kinetics of CYAD-211 in Patients With Relapsed or Refractory Multiple Myeloma

NCT04613557

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Nyu Langone Hospitals New York, United States
  • Universitair Ziekenhuis Antwerpen Antwerp, Belgium
  • Institut Jules Bordet Brussels, Belgium
View Trial Details
Active, Not Recruiting

Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM

NCT03948035

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Univ. Klinikum Krems Krems, Lower Austria, Austria
  • Universitätklinikum St. Pölten Sankt Pölten, Lower Austria, Austria
  • LKH-Universitätsklinikum Graz Graz, Styria, Austria
  • Medizinische Universität Innsbruck Innsbruck, Tyrol, Austria
View all 56 locations
View Trial Details
Active, Not Recruiting

Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma

NCT02544308

Conditions
Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, +4 more
Locations
  • Royal United Hospital Bath, United Kingdom
  • Blackpool Victoria Hospital Blackpool, United Kingdom
  • University Hospital Wales Cardiff, United Kingdom
  • Velindre Cancer Centre Cardiff, United Kingdom
View all 13 locations
View Trial Details
Active, Not Recruiting

Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant

NCT02477878

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +22 more
Locations
  • BMT Program at Northside Hospital Atlanta, Georgia, United States
  • University of Kansas Westwood, Kansas, United States
  • Roswell Park Buffalo, New York, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details
Active, Not Recruiting

An Intensive Program With Quadruplet Induction and Consolidation Plus Tandem Autologous Stem Cell Transplantation in Newly Diagnosed High Risk Multiple Myeloma Patients

NCT03606577

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • CHU de Nantes Nantes, Pays de la Loire Region, France
  • CHU Caen Caen, France
  • CHRU Dijon Dijon, France
  • CHRU - Hôpital A.Michallon Grenoble, France
View Trial Details

Related conditions